Genmab Statistics
Total Valuation
Genmab has a market cap or net worth of 13.21 billion. The enterprise value is 9.88 billion.
Market Cap | 13.21B |
Enterprise Value | 9.88B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 61.50M |
Shares Outstanding | n/a |
Shares Change (YoY) | -61.77% |
Shares Change (QoQ) | +587.81% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 60.81M |
Valuation Ratios
The trailing PE ratio is 11.59 and the forward PE ratio is 13.02.
PE Ratio | 11.59 |
Forward PE | 13.02 |
PS Ratio | 4.09 |
PB Ratio | 2.49 |
P/TBV Ratio | 4.15 |
P/FCF Ratio | 11.40 |
P/OCF Ratio | 11.07 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.88, with an EV/FCF ratio of 8.53.
EV / Earnings | 8.67 |
EV / Sales | 2.83 |
EV / EBITDA | 7.88 |
EV / EBIT | 8.33 |
EV / FCF | 8.53 |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 0.03.
Current Ratio | 5.34 |
Quick Ratio | 5.32 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.12 |
Debt / FCF | 0.12 |
Interest Coverage | 59.70 |
Financial Efficiency
Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 13.34%.
Return on Equity (ROE) | 22.80% |
Return on Assets (ROA) | 11.54% |
Return on Invested Capital (ROIC) | 13.34% |
Return on Capital Employed (ROCE) | 18.83% |
Revenue Per Employee | 1.22M |
Profits Per Employee | 431,963 |
Employee Count | 2,682 |
Asset Turnover | 0.54 |
Inventory Turnover | 11.54 |
Taxes
In the past 12 months, Genmab has paid 183.25 million in taxes.
Income Tax | 183.25M |
Effective Tax Rate | 13.85% |
Stock Price Statistics
The stock price has decreased by -17.99% in the last 52 weeks. The beta is 0.82, so Genmab's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | -17.99% |
50-Day Moving Average | 208.58 |
200-Day Moving Average | 211.03 |
Relative Strength Index (RSI) | 57.24 |
Average Volume (20 Days) | 42 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genmab had revenue of 3.23 billion and earned 1.14 billion in profits. Earnings per share was 18.36.
Revenue | 3.23B |
Gross Profit | 3.07B |
Operating Income | 1.10B |
Pretax Income | 1.32B |
Net Income | 1.14B |
EBITDA | 1.14B |
EBIT | 1.10B |
Earnings Per Share (EPS) | 18.36 |
Balance Sheet
The company has 3.23 billion in cash and 143.00 million in debt, giving a net cash position of 3.08 billion.
Cash & Cash Equivalents | 3.23B |
Total Debt | 143.00M |
Net Cash | 3.08B |
Net Cash Per Share | n/a |
Equity (Book Value) | 5.30B |
Book Value Per Share | 83.61 |
Working Capital | 3.28B |
Cash Flow
In the last 12 months, operating cash flow was 1.19 billion and capital expenditures -35.09 million, giving a free cash flow of 1.16 billion.
Operating Cash Flow | 1.19B |
Capital Expenditures | -35.09M |
Free Cash Flow | 1.16B |
FCF Per Share | n/a |
Margins
Gross margin is 95.12%, with operating and profit margins of 33.97% and 35.27%.
Gross Margin | 95.12% |
Operating Margin | 33.97% |
Pretax Margin | 40.94% |
Profit Margin | 35.27% |
EBITDA Margin | 35.43% |
EBIT Margin | 33.97% |
FCF Margin | 35.87% |
Dividends & Yields
Genmab does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 61.77% |
Shareholder Yield | 61.77% |
Earnings Yield | 8.62% |
FCF Yield | 8.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Genmab has an Altman Z-Score of 9.65 and a Piotroski F-Score of 5.
Altman Z-Score | 9.65 |
Piotroski F-Score | 5 |